{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:23:47Z","timestamp":1774085027225,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Weigand-Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4043-0","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T15:22:05Z","timestamp":1519399325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Sabine","family":"Heublein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Albertsmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Loehrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr V.","family":"Bazhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Kurt","family":"Angele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"8","key":"4043_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1245\/ASO.2005.06.012","volume":"12","author":"AD Cook","year":"2005","unstructured":"Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12(8):637\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"4043_CR2","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","volume":"23","author":"CE Desch","year":"2005","unstructured":"Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ, et al. colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(33):8512\u20139.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"4043_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254\u20139.","journal-title":"Ann Surg"},{"issue":"5","key":"4043_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99(5):699\u2013705.","journal-title":"Br J Surg"},{"issue":"8","key":"4043_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/07357907.2015.1047507","volume":"33","author":"J Neumann","year":"2015","unstructured":"Neumann J, Lohrs L, Albertsmeier M, Reu S, Guba M, Werner J, Kirchner T, Angele M. Cancer stem cell markers are associated with distant Hematogenous liver metastases but not with peritoneal Carcinomatosis in colorectal cancer. Cancer Investig. 2015;33(8):354\u201360.","journal-title":"Cancer Investig"},{"issue":"12","key":"4043_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/DCR.0b013e3182a62d9d","volume":"56","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, van Gestel YR, Lemmens VE, de Hingh IH. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. Dis Colon rectum. 2013;56(12):1373\u201380.","journal-title":"Dis Colon rectum"},{"issue":"3","key":"4043_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1365-2559.2011.04126.x","volume":"60","author":"J Neumann","year":"2012","unstructured":"Neumann J, Horst D, Kriegl L, Maatz S, Engel J, Jung A, Kirchner T. A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer. Histopathology. 2012;60(3):416\u201326.","journal-title":"Histopathology"},{"issue":"4","key":"4043_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"4043_CR9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1078-0432.CCR-12-1703","volume":"19","author":"H Siemens","year":"2013","unstructured":"Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T, Hermeking H. Detection of miR-34a promoter methylation in combination with elevated expression of c-MET and beta-catenin predicts distant metastasis of colon cancer. Clin Cancer Res. 2013;19(3):710\u201320.","journal-title":"Clin Cancer Res"},{"issue":"36","key":"4043_CR10","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"MS LM","year":"2005","unstructured":"LM MS, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. reporting recommendations for tumor marker prognostic studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(36):9067\u201372.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"4043_CR11","volume-title":"miRSAT & miRCDB: an integrated MicroRNA Sequesce analysis tool and a cancer-associated MicroRNA database","author":"B Xie","year":"2010","unstructured":"Xie B, Hochberg R, Ding Q, Wu D: miRSAT & miRCDB: an integrated MicroRNA Sequesce analysis tool and a cancer-associated MicroRNA database; 2010."},{"issue":"5","key":"4043_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","volume":"29","author":"B Xie","year":"2013","unstructured":"Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics. 2013;29(5):638\u201344.","journal-title":"Bioinformatics"},{"key":"4043_CR13","first-page":"21","volume-title":"Big Data Analytics in Bioinformatics and Healthcare","author":"X Boya","year":"2015","unstructured":"Boya X, Qin D, Di W. Text mining on big and complex biomedical literature. In: Baoying W, Ruowang L, William P, editors. Big Data Analytics in Bioinformatics and Healthcare. Hershey: IGI Global; 2015. p. 21\u201345."},{"key":"4043_CR14","unstructured":"http:\/\/mircancer.ecu.edu\/search.jsp last Access 12 Aug 2017."},{"key":"4043_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.3","volume":"2","author":"T Mitamura","year":"2013","unstructured":"Mitamura T, Watari H, Wang L, Kanno H, Hassan MK, Miyazaki M, Katoh Y, Kimura T, Tanino M, Nishihara H, et al. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogene. 2013;2:e40.","journal-title":"Oncogene"},{"issue":"12","key":"4043_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085353","volume":"8","author":"MH Yang","year":"2013","unstructured":"Yang MH, Yu J, Chen N, Wang XY, Liu XY, Wang S, Ding YQ. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2. PLoS One. 2013;8(12):e85353.","journal-title":"PLoS One"},{"issue":"48","key":"4043_CR17","doi-asserted-by":"crossref","first-page":"79617","DOI":"10.18632\/oncotarget.12873","volume":"7","author":"X Yang","year":"2016","unstructured":"Yang X, Xu X, Zhu J, Zhang S, Wu Y, Wu Y, Zhao K, Xing C, Cao J, Zhu H, et al. miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts. Oncotarget. 2016;7(48):79617\u201328.","journal-title":"Oncotarget"},{"issue":"6","key":"4043_CR18","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1007\/s13277-015-4511-y","volume":"37","author":"XB Zhang","year":"2016","unstructured":"Zhang XB, Song L, Wen HJ, Bai XX, Li ZJ, Ma LJ. Upregulation of microRNA-31 targeting integrin alpha5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K\/AKT pathway in human gastric cancer SGC7901 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(6):8317\u201325.","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"2","key":"4043_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm5020017","volume":"5","author":"BN Smith","year":"2016","unstructured":"Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. Journal of clinical medicine. 2016;5(2):17.","journal-title":"Journal of clinical medicine"},{"issue":"1","key":"4043_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33(1):49\u201354.","journal-title":"Nat Genet"},{"issue":"1","key":"4043_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115(1):44\u201355.","journal-title":"J Clin Invest"},{"key":"4043_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","volume":"14","author":"Y Yu","year":"2015","unstructured":"Yu Y, Nangia-Makker P, Farhana L, GR S, Levi E, Majumdar AP. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer. 2015;14:98.","journal-title":"Mol Cancer"},{"issue":"3","key":"4043_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/boc.201500062","volume":"108","author":"A Mamoori","year":"2016","unstructured":"Mamoori A, Gopalan V, Smith RA, Lam AK. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells. Biology of the cell \/ under the auspices of the European Cell Biology Organization. 2016;108(3):51\u201364.","journal-title":"Biology of the cell \/ under the auspices of the European Cell Biology Organization"},{"issue":"13","key":"4043_CR24","doi-asserted-by":"publisher","first-page":"E1550","DOI":"10.1073\/pnas.1503370112","volume":"112","author":"MF Jones","year":"2015","unstructured":"Jones MF, Hara T, Francis P, Li XL, Bilke S, Zhu Y, Pineda M, Subramanian M, Bodmer WF, Lal A. the CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc Natl Acad Sci U S A. 2015;112(13):E1550\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4043_CR25","first-page":"823620","volume":"2015","author":"J Wang","year":"2015","unstructured":"Wang J, Du Y, Liu X, Cho WC, Yang Y. MicroRNAs as regulator of signaling networks in metastatic colon cancer. Biomed Res Int. 2015;2015:823620.","journal-title":"Biomed Res Int"},{"key":"4043_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1476-4598-9-96","volume":"9","author":"B Song","year":"2010","unstructured":"Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol Cancer. 2010;9:96.","journal-title":"Mol Cancer"},{"key":"4043_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.gdata.2014.06.017","volume":"2","author":"L Perilli","year":"2014","unstructured":"Perilli L, Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Rossi E, Esposito G, Rugge M, Pilati P, et al. Human miRNome profiling in colorectal cancer and liver metastasis development. Genomics data. 2014;2:184\u20138.","journal-title":"Genomics data"},{"issue":"1","key":"4043_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1751-2980.2009.00413.x","volume":"11","author":"YX Wang","year":"2010","unstructured":"Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis. 2010;11(1):50\u20134.","journal-title":"J Dig Dis"},{"issue":"7","key":"4043_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/1055-9965.EPI-11-0035","volume":"20","author":"X Luo","year":"2011","unstructured":"Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(7):1272\u201386.","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"4","key":"4043_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.299.4.425","volume":"299","author":"AJ Schetter","year":"2008","unstructured":"Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299(4):425\u201336.","journal-title":"JAMA"},{"issue":"36","key":"4043_CR31","doi-asserted-by":"publisher","first-page":"38695","DOI":"10.18632\/oncotarget.5735","volume":"6","author":"J Mlcochova","year":"2015","unstructured":"Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, et al. MicroRNA expression profiling identifies miR-31-5p\/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. Oncotarget. 2015;6(36):38695\u2013704.","journal-title":"Oncotarget"},{"issue":"1","key":"4043_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.32607\/20758251-2017-9-1-56-67","volume":"9","author":"TS Gerashchenko","year":"2017","unstructured":"Gerashchenko TS, Zavyalova MV, Denisov EV, Krakhmal NV, Pautova DN, Litviakov NV, Vtorushin SV, Cherdyntseva NV, Perelmuter VM. Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor Chemosensitivity. Acta Nat. 2017;9(1):56\u201367.","journal-title":"Acta Nat"},{"issue":"8","key":"4043_CR33","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3748\/wjg.v20.i8.1898","volume":"20","author":"BA Ong","year":"2014","unstructured":"Ong BA, Vega KJ, Houchen CW. Intestinal stem cells and the colorectal cancer microenvironment. World J Gastroenterol. 2014;20(8):1898\u2013909.","journal-title":"World J Gastroenterol"},{"key":"4043_CR34","doi-asserted-by":"publisher","unstructured":"Basu S, Haase G, Ben-Ze\u2019ev A. Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res. 2016;5. Epub 2016\/05\/03. https:\/\/doi.org\/10.12688\/f1000research.7579.1 . PubMed PMID: 27134739; PubMed Central PMCID: PMCPMC4841194.","DOI":"10.12688\/f1000research.7579.1"},{"issue":"2","key":"4043_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11060-013-1211-6","volume":"115","author":"OF Bayrak","year":"2013","unstructured":"Bayrak OF, Gulluoglu S, Aydemir E, Ture U, Acar H, Atalay B, Demir Z, Sevli S, Creighton CJ, Ittmann M, et al. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neuro-Oncol. 2013;115(2):143\u201351.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"4043_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1871520615666150824152353","volume":"16","author":"C Hou","year":"2016","unstructured":"Hou C, Sun B, Jiang Y, Zheng J, Yang N, Ji C, Liang Z, Shi J, Zhang R, Liu Y, et al. MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. Anti Cancer Agents Med Chem. 2016;16(4):501\u201318.","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"5","key":"4043_CR37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"8","key":"4043_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.prp.2015.05.010","volume":"211","author":"H Cao","year":"2015","unstructured":"Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211(8):557\u201369.","journal-title":"Pathol Res Pract"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T16:25:08Z","timestamp":1603902308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4043-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4043-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"13 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out according to the recommendations of the ethics committee of the Medical Faculty of the Ludwig-Maximilians-University Munich, Germany. The current study has been performed in a retrospective manner in a cohort of patients diagnosed and treated according to national guidelines. In addition, the data set as well as the specimens were irreversibly anonymized prior to inclusion in the study. Hence, under the circumstances aforementioned, neither a written consent nor a project specific approval by the ethic committee was necessary.The study was performed according to the standards set in the declaration of Helsinki 1975. All researchers were blinded from patient data during experimental analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study used tumor tissue that had initially been collected for histo-pathological diagnostics. At the time, the tissue was examined for the current study all diagnostic procedures had already been fully completed and the tissue used was thus classified as left-over material. All patient data were fully anonymized. As per declaration of our ethics committee (Ludwig-Maximilians-University Medical School (Munich, Germany)) no written informed consent of the participants is needed given the circumstances described above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"201"}}